Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Evonik
Evonik
Activities:
Ingredients
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Drug Delivery
Evonik begins construction on pharmaceutical lipids facility
The centre will be built on the grounds of Evonik Tippecanoe Laboratories and scheduled to go "onstream" in 2025
Infection Control
Evonik launches plant-based squalene to boost vaccine efficacy
It meets the demand for a secure commercial supply of non-animal-derived squalene
Packaging
Evonik wins CPHI Excellence award for "Packaging and Drug Delivery"
The award was presented at the CPHI pharmaceutical trade show in Frankfurt on November 1, 2022
Finance
Evonik introduces three product lines for health care business
This structural shift is aimed to further transitions the health care business line into a system solutions partner for the pharmaceutical and biotech industries
Manufacturing
Evonik invests in 3D printed tablet tech for controlled delivery
Laxxon Medical’s 3D screen printing technology allows tablets to be constructed in layers of API or inert ingredients
Manufacturing
Evonik increases plant-derived cholesterol supply
The ingredient is used in the manufacture of mRNA vaccines and gene therapies
Manufacturing
Evonik launches updated extruder for liposomal drug manufacturing
LIPEX Flow supports the scale-up of processes from drug discovery through to GMP at lab, pilot, intermediate and commercial-scale volumes
Subscribe now